WCLC 2025 - Posters & ePosters-P2.06.53 TP53 Mutations Drive Therapeutic Resistance in ALK-Rearranged Lung Adenocarcinoma

P2.06.53 TP53 Mutations Drive Therapeutic Resistance in ALK-Rearranged Lung Adenocarcinoma

Asset Subtitle

Meng-Min Wang

Meta Tag

Speaker Meng-Min Wang

Topic Pathology and Biomarkers